(Q89457005)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

editorial

0 references

title

Should we treat individuals homozygous for HFE p.Cys282Tyr with ferritin 300-1000 μg/L? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

publication date

1 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

published in

The Lancet. Haematology.

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

e569-e570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.

5 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

How I treat hemochromatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

Should C282Y homozygotes with mild iron overload be treated?

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2817%2930218-1

7 January 2021

10.1016/S2352-3026(17)30218-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29195601%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference